Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.65%529.54M | -7.75%378.96M | 2.01%369.77M | 17.83%1.69B | 10.83%448.45M | 29.13%470.05M | 25.62%410.79M | 6.59%362.48M | -4.51%1.44B | 3.45%404.63M |
| Cost of revenue | 19.12%1.46B | -4.22%1.23B | ||||||||
| Gross profit | 10.25%230.05M | -6.22%208.65M | ||||||||
| Operating expense | 2.80%89.57M | 12.55%87.13M | ||||||||
| Staff costs | ---- | ---- | ---- | 4.35%82.13M | ---- | ---- | ---- | ---- | 17.29%78.71M | ---- |
| Selling and administrative expenses | ---- | ---- | ---- | 37.44%13.58M | ---- | ---- | ---- | ---- | -12.34%9.88M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | 46.30%1.6M | ---- | ---- | ---- | ---- | 15.02%1.1M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 36.34%11.98M | ---- | ---- | ---- | ---- | -14.86%8.79M | ---- |
| Total other operating income | ---- | ---- | ---- | 318.52%6.15M | ---- | ---- | ---- | ---- | 51.91%1.47M | ---- |
| Operating profit | 21.88%39.54M | -5.53%30.22M | -1.62%30.93M | 15.60%140.48M | 874.54%44.61M | 30.83%32.44M | -30.69%31.99M | -44.18%31.44M | -16.23%121.53M | -122.28%-5.76M |
| Net non-operating interest income (expenses) | -1.96%-12.56M | 26.62%-12.32M | ||||||||
| Non-operating interest income | ---- | ---- | ---- | 19.01%6.68M | ---- | ---- | ---- | ---- | 155.32%5.61M | ---- |
| Non-operating interest expense | -8.84%4.7M | 36.86%6.25M | 4.30%4.59M | 7.31%19.23M | 26.29%5.11M | 5.50%5.16M | 9.87%4.57M | -8.96%4.4M | -5.57%17.92M | -9.25%4.04M |
| Total other finance cost | ---- | ---- | ---- | 0.00%15K | ---- | ---- | ---- | ---- | 0.00%15K | ---- |
| Net investment income | -80.21%1.04M | 85.10%5.23M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | -102.87%-373K | 1.25%12.98M | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 80.31%458K | 216.26%472K | -30.07%307K | -134.67%-233K | -520K | -48.89%254K | -285.39%-406K | 232.58%439K | 247.37%672K | |
| Special income (charges) | 5,855.74%3.51M | -365.22%-61K | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | 385.25%296K | ---- | ---- | ---- | ---- | 408.33%61K | ---- |
| Less:Write off | ---- | ---- | ---- | ---3.81M | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | -75.74%147K | 388.71%606K | ||||||||
| Income before tax | 28.18%35.3M | -9.53%24.44M | -3.02%26.65M | 2.62%132M | 247.55%49.96M | 34.96%27.54M | -36.00%27.02M | -46.77%27.48M | -10.43%128.63M | -62.62%14.38M |
| Income tax | 33.37%9.5M | -23.21%5.51M | 149.72%18.1M | 22.45%38.47M | 742.26%16.92M | 39.63%7.12M | -33.32%7.18M | -46.49%7.25M | -25.50%31.42M | -81.20%2.01M |
| Net income | 26.36%25.8M | -4.58%18.93M | -57.74%8.55M | -3.79%93.53M | 167.19%33.04M | 33.40%20.41M | -36.92%19.84M | -46.88%20.23M | -4.17%97.22M | -55.47%12.37M |
| Net income continuous operations | 26.36%25.8M | -4.58%18.93M | -57.74%8.55M | -3.79%93.53M | 167.19%33.04M | 33.40%20.41M | -36.92%19.84M | -46.88%20.23M | -4.17%97.22M | -55.47%12.37M |
| Noncontrolling interests | -11.84%5.4M | 59.60%4.99M | -58.48%830K | 16.00%14.11M | -4.40%2.87M | 75.94%6.12M | 3.82%3.12M | -25.35%2M | 287.79%12.17M | 55.31%3M |
| Net income attributable to the company | 42.73%20.4M | -16.57%13.95M | -57.66%7.72M | -6.62%79.42M | 222.12%30.18M | 20.88%14.29M | -41.23%16.72M | -48.50%18.24M | -13.48%85.05M | -63.74%9.37M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 42.73%20.4M | -16.57%13.95M | -57.66%7.72M | -6.62%79.42M | 222.12%30.18M | 20.88%14.29M | -41.23%16.72M | -48.50%18.24M | -13.48%85.05M | -63.74%9.37M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 41.18%0.024 | -17.50%0.0165 | -58.14%0.009 | -6.90%0.0945 | 208.70%0.0355 | 21.43%0.017 | -41.18%0.02 | -48.81%0.0215 | -13.25%0.1015 | -62.30%0.0115 |
| Diluted earnings per share | 41.18%0.024 | -17.50%0.0165 | -58.14%0.009 | -6.90%0.0945 | 208.70%0.0355 | 21.43%0.017 | -41.18%0.02 | -48.81%0.0215 | -13.25%0.1015 | -62.30%0.0115 |
| Dividend per share | 0.04 | 0.00%0.035 | 0 | 0.00%0.07 | 0.035 | 0 | 0.00%0.035 | 0 | 100.00%0.07 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.